Skip to main content


Fig. 5 | Cardiovascular Diabetology

Fig. 5

From: Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome

Fig. 5

Effect of long-term (10 weeks) empagliflozin treatment on epididymal (a) and subcutaneous (b) fat tissue TBARS of SHRcp. Control SHRcp fed control diet; SGLT2, SHRcp fed control diet containing empagliflozin; UGE urinary glucose excretion; NS not significant. Values are mean ± SEM n = 11–12 in control, n = 12 in SGLT2. Statistical analysis was performed by unpaired Student’s t test

Back to article page